跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 0.5MG - HSA Drug Approval Details
Approvals
/
HSA
/
TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 0.5MG
Approved
STANDARD
TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 0.5MG
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
0360a3de855c5ae6
Company
Unknown
Type
Standard
Approval Details
Approval Id
0360a3de855c5ae6
Drug Name
TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 0.5MG
Active Ingredients
Tacrolimus monohydrate eqv tacrolimus
0.5 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
0360a3de855c5ae6
Type
Standard
Back to HSA Approvals
